Renalytix Plc (AIM: RENX)
Health Care · Health Care Technology · GB
£0.04
+10.39% today · -33.0% 1Y
Renalytix Plc (AIM: RENX) operates in the Health Care Technology industry within the Health Care sector. The company is valued at $22.93M.
Over the last twelve months the share price has lost 33.0%, trading between 0.02 and 0.16.
Tweenvest scores Renalytix Plc across four factors: quality 10/100, value 56/100. Its strongest factor is value.
RENX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $22.93M
- Revenue (TTM)
- $3.30M
- P/E
- —
- EPS
- -0.05
- Dividend yield
- —
- Beta (5Y)
- 1.81
- 52-week high
- £0.16
- 52-week low
- £0.02
- Avg volume (3M)
- —
- Shares outstanding
- 437.02M
- Employees
- —
- Next earnings
- —
Other Health Care Technology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Veeva Systems Inc.NYSE: VEEV | $40.27B | $247.90 | -1.05% |
| Pro Medicus LimitedASX: PME | $14.35B | AU$191.60 | -6.99% |
| M3, Inc.TSE: 2413 | $7.17B | ¥1,708.00 | -2.43% |
| Sectra AB (publ)OM: SECT B | $5.66B | Skr278.00 | -1.35% |
| Waystar Holding Corp.NasdaqGS: WAY | $4.80B | $25.01 | +0.68% |
| Doximity, Inc.NYSE: DOCS | $4.51B | $25.33 | -2.35% |
| HeartFlow, Inc.NasdaqGS: HTFL | $3.66B | $49.66 | +18.01% |
| Inventurus Knowledge Solutions LimitedNSEI: IKS | $3.30B | Rs1,840.00 | +6.43% |
Figures last refreshed Aug 18, 2026.